AVADEL PHARMACEUTICALS PLC — Director's Dealing 2016

Mar 21, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLAMEL TECHNOLOGIES SA (FLML)
CIK: 0001012477
Period of Report: 2016-03-18

Reporting Person: Hatten Sandra L (Sr. VP, Quality & Reg Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-18	ADSs	P	3000	$11.01	Acquired	3000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$21.67	2025-06-26	ADSs (100000)	100000	Direct
Stock Option (right to buy)	$14.35	2025-12-10	ADSs (50000)	50000	Direct

Footnotes

F1: The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value 0.122 Euros per share, of the issuer; ADSs are represented by American Depositary Receipts.

F2: Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 06/26/2015 grant date.

F3: Options become exercisable as to 12,500 ADSs on each of the first four anniversaries after the 12/10/2015 grant date.